Preclinical Toxicology of Small Molecule Drugs Developed for Cancer and Other Indications
Award Notice Posted
- Solicitation number
- 75N91021R00003
- Agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Awarded
- to IIT Research Institute
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N91022D000016 Federal IDV award
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- United States
Notice details come from SAM.gov. Updated .
Notice text
A Single Award Indefinite Delivery, Indefinite Quantity (IDIQ) contract was awarded in support of the Preclinical Toxicology of Small Molecule Drugs Developed for Cancer and Other Indications Program under RFP No: 75N91021R00003.
Awarded contract 75N91022D000016 to IIT Research Institute for 9838435.00 on 2022-09-23.
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Award Notice | |
| Preclinical Toxicology of Small Molecule Drugs Developed for Cancer and Other Indications | Special Notice | |
| Preclinical Toxicology of Small Molecule Drugs Developed for Cancer and Other Indications | Solicitation | |
| Preclinical Toxicology of Small Molecule Drugs Developed for Cancer and Other Indications | Pre-Solicitation | |
| Preclinical Toxicology of Small Molecule Drugs Developed for Cancer and Other Indications | Pre-Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity